Advertisement

Topics

Lysando AG Company Profile

02:51 EDT 25th September 2018 | BioPortfolio

Lysando AG is a technology leader in the area of antimicrobial proteins. Since its foundation in 2009, the privately financed research company has done research on artificial designer proteins with a team of scientists in the town of Regensburg. Artilysin®s represent a revolutionary breakthrough in the battle against multi-resistant bacteria. With this new technology platform, drugs and substances against pathogenic gram-negative and gram-positive bacteria can be specifically developed, both for antibiotic-resistant and persisting bacteria. With Artilysin®s, Lysando has created an effective alternative to antibiotics.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Lysando AG

Lysando AG is a technology leader in the area of antimicrobial proteins. Since its foundation in 2009, the privately financed research company has done research on artificial desi...

More Information about "Lysando AG" on BioPortfolio

We have published hundreds of Lysando AG news stories on BioPortfolio along with dozens of Lysando AG Clinical Trials and PubMed Articles about Lysando AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lysando AG Companies in our database. You can also find out about relevant Lysando AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record